Galenica: new medine registration platform

30-01-2008 | |

Sequent Scientific Ltd., based in Bangalore, India, and Orffa International Holding B.V. headquartered in Werkendam, the Netherlands have established Galenica B.V.,a joint venture company, according to Dutch law. This newly founded company will act as a registration platform for new generic veterinarian drug registration according to the latest European guidelines.

The objective of Galenica is to exploit the synergies
between the outstanding registration and production competences of Sequent
Scientific, and the market knowledge as well as the network of Orffa
International, in order to develop in a close collaboration with the
veterinarian laboratories, new EU level registration for existing and new
generic drugs. This in view of the ever more strict registration procedures
imposed on the veterinarian industry, which renders the registration of generic
drugs time-consuming and expensive.

About the companies
Scientific Ltd, formerly known as Strides Research & Specialty Chemicals
td., is a company engaged in contract research, analysis, manufacturing of
specialty chemicals, niche APIs and Animal Health. Sequent group is India’s
largest producer of Animal Health API. Sequent is aiming at the development and
production of veterinarian drugs on a global basis, and has as main USP’s its
scientific development departments, specialised in drug development, as well as
its state of the art, GMP qualified production sites.

International Holding B.V. is a leading European marketing and sales company,
active in the animal health and nutrition market. Orffa has an extensive global
network of suppliers of high quality ingredients for animal feeds and
veterinarian drugs. Orffa has contacts with over 1000 customers, from
veterinarian laboratories to feed operators. Orffa enjoys strong partnerships
with leading producers of active pharmaceutical ingredients for veterinarian

Related websites:

To receive more animal feed news, subscribe here for

More about

2/3 articles remaining | Register to continue reading.